Find a Specialist by Postal Code | Aplastic Anemia & MDS International Foundation Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Lead Photo Name Current Institution City Province Country Primary disease area of focus
Omar Abdel-Wahab, MD Memorial Sloan-Kettering Cancer Center New York City New York United States
  • acute myeloid leukemia (AML)
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
Gregory Abel, MD, MPH Dana-Farber Cancer Institute Bosotn Massachusetts United States
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
Lionel Ades, MD, PhD Hôpital Saint-Louis Paris France
  • acute myeloid leukemia (AML)
  • myelodysplastic syndromes (MDS)
Suneet Agarwal, MD, PhD Boston's Children's Hospital Boston Massachusetts United States
  • aplastic anemia
  • pediatric
Mojtaba Akhtari, MD Loma Linda University Cancer Center Loma Linda California United States
  • acute myeloid leukemia (AML)
  • aplastic anemia
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
  • paroxysmal nocturnal hemoglobinuria (PNH)
Blanche Alter, MD National Cancer Institute - NCI Bethesda Maryland United States
Amanda Przespolewski, DO Roswell Park Comprehensive Cancer Center Buffalo New York United States
  • acute myeloid leukemia (AML)
  • aplastic anemia
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
  • paroxysmal nocturnal hemoglobinuria (PNH)
Joseph H Antin, MD Dana-Farber Cancer Institute Boston Massachusetts United States
  • aplastic anemia
  • paroxysmal nocturnal hemoglobinuria (PNH)
Cecilia Arana Yi, MD, MSHS, FACP Mayo Clinic, Phoenix, AZ Phoenix Arizona United States
  • acute myeloid leukemia (AML)
  • aplastic anemia
  • chronic lymphocytic leukemia (CLL)
  • chronic myelomonocytic leukaemia (CMML)
  • graft versus host disease (GVHD)
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
  • paroxysmal nocturnal hemoglobinuria (PNH)
  • pure red cell aplasia (PRCA)
David Araten, MD NYU Hematology Associates New York City New York United States
  • paroxysmal nocturnal hemoglobinuria (PNH)
Mary Armanios, MD Johns Hopkins University Baltimore Maryland United States
Staci Arnold, MD, MBA, MPH Children's Healthcare of Atlanta Atlanta Georgia United States
  • aplastic anemia
  • myelodysplastic syndromes (MDS)
  • paroxysmal nocturnal hemoglobinuria (PNH)
  • pediatric
Ehab Atallah, MD Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin United States
  • acute myeloid leukemia (AML)
  • aplastic anemia
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
Daria Babushok, MD, PhD Hospital of the University of Pennsylvania Philadelphia Pennsylvania United States
  • aplastic anemia
  • myeloproliferative neoplasms (MPN)
  • paroxysmal nocturnal hemoglobinuria (PNH)
Maria Baer, MD University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland United States
  • acute myeloid leukemia (AML)
  • aplastic anemia
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
Suresh Balasubramanian Karmanos Cancer Institute Detroit Michigan United States
  • acute myeloid leukemia (AML)
  • aplastic anemia
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
  • paroxysmal nocturnal hemoglobinuria (PNH)
  • pure red cell aplasia (PRCA)
Suresh Balasubramian, MD Karmanos Cancer Institute Detroit Michigan United States
  • acute myeloid leukemia (AML)
  • aplastic anemia
  • chronic lymphocytic leukemia (CLL)
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
  • paroxysmal nocturnal hemoglobinuria (PNH)
Taha Bat, MD UT Southwestern Medical Center Dallas Texas United States
  • aplastic anemia
  • paroxysmal nocturnal hemoglobinuria (PNH)
David Beck, MD, PhD NYU Grossman School of Medicine New York New York United States
Pamela Becker, MD, PhD Beckman Research Center at City of Hope Duarte California United States
  • acute myeloid leukemia (AML)
  • aplastic anemia
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)

Disclaimer

By using this feature you agree to the following: The Aplastic Anemia and MDS International Foundation (AAMDSIF) Find a Specialist search feature is for informational purposes only and does not constitute medical advice. The feature is intended only to provide information and assistance in locating physicians with experience in treating aplastic anemia, myelodysplastic syndrome (MDS), paroxysmal nocturnal hemoglobinuria (PNH), and related bone marrow failure diseases. AAMDSIF does not (and cannot) warrant that the information is accurate or complete. Furthermore, the feature does not contain all of the physicians with experience with these diseases and AAMDSIF does not endorse any specific physician. In no event shall AAMDSIF be liable for any decision made or action taken in reliance on the information contained therein. AAMDSIF always recommends that you conduct your own research into the health care provider(s) that you choose. If you have any questions regarding this feature or the information contained therein, please contact help@aamds.org.

Please also note that our physicians may move from institution to institution for various reasons. While we do our best to keep our map up to date, you may encounter a situation where physician is no longer listed at the institution provided. If a selected physician is no longer at the institution listed, please reach out to our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a physician in your area.

Neither the database, nor any part of the data, listings, profiles, or other constituent elements may be downloaded, republished, or duplicated, in whole or in part, for commercial purposes, purposes of compiling a mailing list or any other list of doctors, or for any other purposes without the prior express written permission of the AAMDSIF.

Specialists at the National Institutes of Health (NIH)

The National Institutes of Health, a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency based in Bethesda, Maryland. NIH only enrolls patients who are participating in a clinical study. The database of clinical studies being conducted by NIH is accessible at Search the Studies. If you have any questions about participating in a clinical study at NIH, please contact the Office of Patient Recruitment at: 1-800-411-1222, TTY 1-866-411-1010. For additional information about NIH clinical trials, visit https://www.nih.gov/health-information/nih-clinical-research-trials-you.

Share with addtoany.com.